Manchester Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Manchester Capital Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,550	Closed	-$158K	–	688
2015 Q4	$158K	Hold	2,550	–	–	0.02%	242
2015 Q3	$145K	Buy	+2,550	New	+$135K	0.02%	240
2015 Q1	–	Sell	-1,350	Closed	-$58K	–	955
2014 Q4	$58K	Sell	1,350 -1,350	-50%	-$55.2K	0.01%	687
2014 Q3	$93K	Hold	2,700	–	–	0.01%	591
2014 Q2	$99K	Hold	2,700	–	–	0.01%	561
2014 Q1	$91K	Buy	2,700 +1,350	+100%	+$44.5K	0.01%	544
2013 Q4	$46K	Sell	1,350 -1,200	-47%	-$41.6K	0.01%	607
2013 Q3	$81K	Hold	2,550	–	–	0.01%	498
2013 Q2	$58K	Buy	+2,550	New	+$55.2K	0.01%	562

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Manchester Capital Management's CMD Position: Q1 2016 in Review

Manchester Capital Management sold out of Cantel Medical Corporation (CMD) in Q1 2016, closing a stake of 2,550 shares — an estimated $158K sold.

Manchester Capital Management first reported a position in CMD in Q2 2013 and held it in 9 quarters. The position peaked at $158K in Q4 2015. 218 funds tracked by Wall St. Rank hold CMD as of Q1 2016.

Manchester Capital Management reported no remaining Cantel Medical Corporation position as of Q1 2016 after selling out during the quarter.
Manchester Capital Management sold 2,550 Cantel Medical Corporation shares in Q1 2016, an estimated $158K.
Manchester Capital Management first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 9 quarters.
Manchester Capital Management's Cantel Medical Corporation position peaked at $158K in Q4 2015.
218 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2016.

Based on Manchester Capital Management's 13F filing for Q1 2016, filed 4 May 2016.